Jean-maurice Mallet

Dr. Jean-maurice Mallet

Ecole Normale Superieure in Paris
+1
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2012 in Gut
Verified
Journal Article
Closed access
PDF file
HDHenri Duboc
Henri Duboc
SRSylvie Rajca
Sylvie Rajca
DRDominique Rainteau
Dominique Rainteau
DBDavid Benarous
David Benarous
MMMarie-Anne Maubert
Marie-Anne Maubert
PSPhilippe SEKSIK
Philippe SEKSIK
Objective: Gut microbiota metabolises bile acids (BA). As dysbiosis has been reported in inflammatory bowel diseases (IBD), we aim to investigate the impact of IBD-associated dysbiosis on BA metabolism and its influence on the epithelial cell inflammation response. Design: Faecal and serum BA rates, expressed as a proportion of total BA, were assessed by high-performance liquid chromatography tandem mass spectrometry in colonic IBD patients (42) and healthy subjects (29). The faecal microbiota composition was assessed by quantitative real-time PCR. Using BA profiles and microbiota composition, cluster formation between groups was generated by ranking models. The faecal BA profiles in germ-free and conventional mice were compared. Direct enzymatic activities of BA biotransformation were measured in faeces. The impact of BA on the inflammatory response was investigated in vitro using Caco-2 cells stimulated by IL-1β. Results: IBD-associated dysbiosis was characterised by a decrease in the ratio between Faecalibacterium prausntizii and Escherichia coli . Faecal-conjugated BA rates were significantly higher in active IBD, whereas, secondary BA rates were significantly lower. Interestingly, active IBD patients exhibited higher levels of faecal 3-OH-sulphated BA. The deconjugation, transformation and desulphation activities of the microbiota were impaired in IBD patients. In vitro, secondary BA exerted anti-inflammatory effects, but sulphation of secondary BAs abolished their anti-inflammatory properties. Conclusions: Impaired microbiota enzymatic activity observed in IBD-associated dysbiosis leads to modifications in the luminal BA pool composition. Altered BA transformation in the gut lumen can erase the anti-inflammatory effects of some BA species on gut epithelial cells and could participate in the chronic inflammation loop of IBD.

22 December 2014 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YOYo Otsu
Yo Otsu
KCKiri Couchman
Kiri Couchman
DLDeclan G Lyons
Declan G Lyons
MCMayeul Collot
Mayeul Collot
AAAmit Agarwal
Amit Agarwal
SCSerge Charpak
Serge Charpak

1 May 2006 in Gastroenterology
Verified
Journal Article
Closed access
ASAnnie Standaert
Annie Standaert
TJThierry Jouault
Thierry Jouault
PVPeggy Vandewalle
Peggy Vandewalle
CMCéline Mille
Céline Mille
MSMimouna Seddik
Mimouna Seddik
DPDaniel Poulain
Daniel Poulain

1 June 2012 in Journal of Chromatography B
Verified
Journal Article
Closed access
LHLydie Humbert
Lydie Humbert
MMMarie Anne Maubert
Marie Anne Maubert
CWClaude Wolf
Claude Wolf
HDHenri Duboc
Henri Duboc
MMMyriam Mahé
Myriam Mahé
DRDominique Rainteau
Dominique Rainteau

11 August 2007 in Nano Letters
Verified
Journal Article
Closed access
José Manuel Costa FernándezJosé Manuel Costa Fernández
José Manuel Costa Fernández
AYAleksey Yakovlev
Aleksey Yakovlev
RSRalph A. Sperling
Ralph A. Sperling
CLCamilla Luccardini
Camilla Luccardini
SGStéphane Gaillard
Stéphane Gaillard
WPWolfgang Parak
Wolfgang Parak

7 September 2010 in ACS Nano
Verified
Journal Article
Closed access
DPDuane E. Prasuhn
Duane E. Prasuhn
AFAnne Feltz
Anne Feltz
JBJuan B. Blanco-Canosa
Juan B. Blanco-Canosa
KSKimihiro Susumu
Kimihiro Susumu
MSMichael H. Stewart
Michael H. Stewart
Igor MedintzIgor Medintz
Igor Medintz